Biopanda Drugs of Abuse Rapid Tests

| October 11, 2019

article image
Biopanda Drugs of Abuse Multi Rapid Tests. Cassette and Panel Tests can be manufactured for our customer's specific requirements. Choose from over 40 drugs of abuse.

Spotlight

Bio-Pharm Inc.

Bio-Pharm, Inc. is a leading supplier of generic pharmaceutical formulations, where we constantly "build quality at every level." With deep dedication and a proactive approach to developing new products, Bio-Pharm invests heavily in R&D. Our state-of-the-art facilities compliment our talented scientists to deliver quality products on demand. Pharmaceutical manufacturing and research may start in a laboratory, but it ends with an individual - a living and breathing person. Our goal is to develop innovative and high-quality pharmaceuticals to improve millions of lives, one product at a time.

OTHER ARTICLES

Pricing of drugs – at what cost?

Article | February 27, 2020

We go into a doctor’s office and leave with a diagnosis and a prescription. Next we stop by the pharmacy. In Germany, if your insurance is not private, you mostly don’t even know the price of your drug because it’s paid for directly by your insurance. You only notice the 5-10 Euros copay. But how is a drug priced in Germany? And (how) does data play a role in helping pharma secure an attractive price point? Let’s fast forward directly to the launch of a new drug. At the time of launch, the pharmaceutical company has to present patient level evidence of the drug’s added value compared to existing comparative therapies. In the first year, however, the drug’s price can be defined freely by the company.

Read More

5 Pharma Trends and Their Impact on Packaging

Article | February 27, 2020

The pharmaceutical industry is changing at an unprecedented pace. New biological treatments for cancer, and a dramatic rise of widespread diseases such as diabetes, call for new processing and packaging solutions to fulfill the different needs all over the world. Keep your eye on these five main packaging trends for 2020 for the global pharmaceutical market.

Read More

Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?

Article | April 1, 2020

Pharmaceutical stocks have been somewhat of a safe haven for investors as the coronavirus outbreak spread from China to the rest of the world. But as the pandemic deepened, now resulting in more than 782,000 cases worldwide, even these "safer" companies are beginning to feel the effects. The U.S. is now the coronavirus epicenter, with the most cases -- more than 161,000 as of today. Initial concerns for drugmakers had to do with the supply of active pharmaceutical ingredients, which often come from China. The worry was that pharmaceutical companies wouldn't be able to produce enough of their drugs for patients.

Read More

Global Antiviral Drugs Market Growth: Is Antiviral Drug the Best Coronavirus Treatment?

Article | April 9, 2020

The global antiviral drugs market has witnessed a rapid surge in demand due to the ongoing Covid-19 pandemic worldwide. So is antiviral drug the best coronavirus treatment? It is still too early to have that conclusion as many medical research and clinical trials are still trying to find the effectiveness and potential side effects of using antiviral drugs to treat coronavirus. But experts believe that antiviral drug might be the best hope for reduce the coronavirus transmission around the world at this stage. However, due to the current difficult situation of the supply chain in many lockdown countries and regions, there is a global shortage on the antiviral drugs supply. With researchers and manufacturers working hard to find and provide effective coronavirus treatment, it is expected that the global antiviral drugs market will have a significant growth over the near future. Antiviral drugs are a type of medication used specifically for treating viral infections, such as human immunodeficiency virus (HIV), hepatitis, and influenza.

Read More

Spotlight

Bio-Pharm Inc.

Bio-Pharm, Inc. is a leading supplier of generic pharmaceutical formulations, where we constantly "build quality at every level." With deep dedication and a proactive approach to developing new products, Bio-Pharm invests heavily in R&D. Our state-of-the-art facilities compliment our talented scientists to deliver quality products on demand. Pharmaceutical manufacturing and research may start in a laboratory, but it ends with an individual - a living and breathing person. Our goal is to develop innovative and high-quality pharmaceuticals to improve millions of lives, one product at a time.

Events